CVS Health Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 47 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 93.94.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of CVS Health Corp is 5.42, ranking 70 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 100.43B, representing a year-over-year increase of 6.17%, while its net profit experienced a year-over-year increase of 65.43%.
Key Metrics
The current valuation score of CVS Health Corp is 8.55, ranking 8 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 39.43, which is 466.01% below the recent high of 223.18 and 76.19% above the recent low of 9.39.
The current earnings forecast score of CVS Health Corp is 8.07, ranking 27 out of 75 in the Healthcare Providers & Services industry. The average price target is 93.00, with a high of 102.00 and a low of 79.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of CVS Health Corp is 9.68, ranking 4 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 96.03 and the support level at 79.92, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of CVS Health Corp is 7.00, ranking 33 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 90.28%, representing a quarter-over-quarter decrease of 1.19%. The largest institutional shareholder is The Vanguard, holding a total of 114.91M shares, representing 9.01% of shares outstanding, with 3.23% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for CVS Health Corp. The Healthcare Providers & Services industry's average is 5.73. The company's beta value is 0.60. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
